Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Marciniak, Marta Anna; Shanahan, Lilly; Myin-Germeys, Inez et al.

Imager-A mobile health mental imagery-based ecological momentary intervention targeting reward sensitivity: A randomized controlled trial

APPLIED PSYCHOLOGY-HEALTH AND WELL BEING. 2023


Moos, S.; Mohebiany, A. N.; Waisman, A. et al.

Imiquimod-induced psoriasis-like dermatitis in mice depends on IL-17 signaling of keratinocytes

EXPERIMENTAL DERMATOLOGY. Bd. 32. H. 4. 2023 S. E26-E26



Sebastian-Alexander, Tolke; Thomas, Masetto; Thomas, Reuschel et al.

Immunoaffinity LC-MS/MS Quantification of the Sepsis Biomarker Procalcitonin Using Magnetic- and Polystyrene-Bead Immobilized Polyclonal Antibodies

JOURNAL OF PROTEOME RESEARCH. Bd. 22. H. 10. 2023 S. 3135-3148


Lordick, Florian; Thuss-Patience, Peter; Bitzer, Michael et al.

Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 149. H. 9. 2023 S. 5937-5950


Krenzlin, Viola; Schoche, Johannes; Walachowski, Sarah et al.

Immunomodulation of neutrophil granulocyte functions by bacterial polyphosphates

EUROPEAN JOURNAL OF IMMUNOLOGY. 2023


Buonfiglio, Francesco; Pfeiffer, Norbert; Gericke, Adrian

Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment

PHARMACEUTICALS. Bd. 16. H. 9. 2023


Tubio-Santamaria, Nuria; Jayavelu, Ashok Kumar; Schnoeder, Tina M. et al.

Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia

MOLECULAR CANCER. Bd. 22. H. 1. 2023



Schuckmann, Aaron; Steffen, Falk; Zipp, Frauke et al.

Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis

MED. Bd. 4. H. 6. 2023 S. 361-+